Stocks
UiPath
Robotic process automation moving toward agentic workflows.
Market data uses cached snapshots: prices refresh after 15 minutes, company details after 24 hours, and financials and corporate actions after 12 hours. Prices are completed-session closes, not live quotes.
Price snapshot retrieved . This is the retrieval time, not the trading-session time.
Some market snapshots are awaiting refresh or the provider is unavailable. Figures may be out of date; check the dates before using them.
PATH key data
About UiPath
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies, including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service. The company works in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific, with the maximum revenue from the America.
UiPath websitePATH price chart
Daily open, high, low and close with volume.
Quotes are delayed at least 15 minutes.
PATH technical indicators
Computed daily from PATH's own price history — not third-party ratings. Technical analysis describes past price behaviour; it is information, not investment advice.
Fibonacci retracement
Based on PATH's high/low over the same history as the chart above.
PATH annual investment, R&D and cash flow
Quarterly highlights and original SEC reports
Verified annual USD facts from SEC filings. Collected .
| Annual period | Revenue | Cash capex | Productive asset purchases | Operating cash flow | Free cash flow | R&D | R&D / revenue |
|---|---|---|---|---|---|---|---|
| to | $1.61 billion | $19.05 million | Not available | $371.21 million | $352.16 million | $385.21 million | 23.9% |
|
RevenueFromContractWithCustomerExcludingAssessedTax · 10-K filed · accession 0001734722-26-000012
NetCashProvidedByUsedInOperatingActivities · 10-K filed · accession 0001734722-26-000012
PaymentsToAcquirePropertyPlantAndEquipment · 10-K filed · accession 0001734722-26-000012
ResearchAndDevelopmentExpense · 10-K filed · accession 0001734722-26-000012
|
|||||||
| to | $1.43 billion | $14.92 million | Not available | $320.57 million | $305.64 million | $380.68 million | 26.6% |
|
RevenueFromContractWithCustomerExcludingAssessedTax · 10-K filed · accession 0001734722-26-000012
NetCashProvidedByUsedInOperatingActivities · 10-K filed · accession 0001734722-26-000012
PaymentsToAcquirePropertyPlantAndEquipment · 10-K filed · accession 0001734722-26-000012
ResearchAndDevelopmentExpense · 10-K filed · accession 0001734722-26-000012
|
|||||||
| to | $1.31 billion | $7.34 million | Not available | $299.08 million | $291.74 million | $332.1 million | 25.4% |
|
RevenueFromContractWithCustomerExcludingAssessedTax · 10-K filed · accession 0001734722-26-000012
NetCashProvidedByUsedInOperatingActivities · 10-K filed · accession 0001734722-26-000012
PaymentsToAcquirePropertyPlantAndEquipment · 10-K filed · accession 0001734722-26-000012
ResearchAndDevelopmentExpense · 10-K filed · accession 0001734722-26-000012
|
|||||||
| to | $1.06 billion | $23.82 million | Not available | -$9.98 million | -$33.8 million | $285.75 million | 27.0% |
|
RevenueFromContractWithCustomerExcludingAssessedTax · 10-K filed · accession 0001734722-25-000007
NetCashProvidedByUsedInOperatingActivities · 10-K filed · accession 0001734722-25-000007
PaymentsToAcquirePropertyPlantAndEquipment · 10-K filed · accession 0001734722-25-000007
ResearchAndDevelopmentExpense · 10-K filed · accession 0001734722-25-000007
|
|||||||
SEC filing data: definitions, coverage and revisions
Source: the SEC Company Facts API, using standard US GAAP facts in USD from annual 10-K, 20-F or 40-F filings and amendments. Periods must span 300-400 days. Quarterly and year-to-date values are not presented as annual totals.
- Cash capex is cash payments to acquire property, plant and equipment. It excludes broader acquisition or intangible-asset tags and is not total AI spending or an estimate of finance-lease investment.
- Productive asset purchases are a separately reported, broader cash investment measure. They are shown in their own column and never substituted into PP&E capex, capital intensity or free cash flow. Do not rank mixed definitions as if they were identical.
- Free cash flow here is operating cash flow minus cash capex. It may differ from a company's adjusted free cash flow definition. If either input is missing, the result is omitted.
- R&D intensity is reported research and development expense divided by revenue from the same annual reporting period. Operating cash margin and capital intensity use the same-period revenue denominator.
- Figures are company-wide, not AI-specific or segment-level. Financial years differ, so compare the displayed start and end dates rather than assuming calendar-year alignment.
- The latest available filing for each supported fact is used, including restated comparative figures. Conflicting values from equally recent reports are omitted. Every figure retains its XBRL tag, accession and filing date.
Company-specific extension tags, IFRS-only data and unsupported definitions are not estimated. Missing standard facts are shown as unavailable, not zero. Data is refreshed in the background; the collection time is separate from the filing date.
PATH vs. related companies
Compare reported revenue growth, profitability and valuation. Related companies can have different business models and fiscal calendars.
| Company | Latest close | Revenue growth (YoY) | Net margin (TTM) | P/E (TTM) | P/S (TTM) |
|---|---|---|---|---|---|
| UiPath (PATH) | $13.94 | — | — | — | — |
| Microsoft (MSFT) | $521.08 | — | — | — | — |
| Alphabet (GOOGL) | $324.22 | — | — | — | — |
| NVIDIA (NVDA) | $212.21 | — | — | — | — |
| Snowflake (SNOW) | $313.96 | — | — | — | — |
| Salesforce (CRM) | $250.29 | — | — | — | — |
Related companies are drawn from our coverage universe and may operate in different industries. Prices reflect the latest available market close.
About the data and comparisons
Stock prices reflect the latest available market close. Market capitalisation and financial results may have different reporting dates; refer to the dates shown when comparing companies.
- Revenue growth compares the latest fiscal quarter with the same fiscal quarter a year earlier. Missing or ambiguous comparison periods are not estimated.
- TTM means trailing twelve months. Comparisons require four reported quarters with consistent USD units; unknown or other currencies are not converted or mixed. Net margin is TTM net income divided by TTM revenue.
- P/E uses the displayed close divided by TTM diluted EPS and is omitted for non-positive earnings. P/S uses reference market capitalisation divided by positive TTM revenue; it is not enterprise value to sales.
- Financial figures cover the whole company unless a business segment is specified. Inclusion in an AI theme does not indicate the share of revenue generated by AI.
- Fiscal calendars and reporting dates differ. Check each row's period end and filing date before comparing. Missing values are shown as —, not zero; funds do not receive operating-company ratios.
Theme membership is editorial, not an investment recommendation or a complete market universe. Compare similar business models and verify financial statements through the company website linked on each stock page.
PATH frequently asked questions
What is the PATH stock price today?
UiPath (PATH) last closed at $13.94 on October 22, 2026. Quotes are delayed at least 15 minutes.
What is the 52-week range for PATH?
Over the past 52 weeks PATH has traded between $9.20 and $19.84.
What is UiPath's market cap?
UiPath has a market capitalisation of about $7.15 billion.
Which exchange is PATH listed on?
PATH trades on NYSE, in the Services-Prepackaged Software industry.
Is PATH overbought or oversold?
PATH's 14-day relative strength index (RSI) is 54.7, which is neutral on the standard 30/70 scale. RSI measures the speed of recent price moves, not a price target — this is not investment advice.
Is PATH in an uptrend or downtrend?
PATH's 50-day moving average is currently above its 200-day moving average — a Golden Cross (bullish long-term trend) in classic technical-analysis terms. Moving-average crossovers describe past price behaviour, not a forecast.
PATH sectors
Others in Cloud & software
Related stocks
Coverage is for information only and is not investment advice. Stock prices can move quickly and past performance does not guarantee future results.
Quotes are delayed at least 15 minutes. Last updated .